Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Key: Satellos Bioscience (0) Acquired (2)
ico-007 (2 trials)
ranibizumab (lucentis) (1 trial)
Trials (2 total)
Trial APIs (2 total)